A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy

Nadia M. Al-Wardy, Mohammed N. Al-Kindi, Mazin J. Al-Khabouri, Yahya Tamimi, Guy Van Camp

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: To identify genetic defects in an Omani family diagnosed with deafness. Original Articles Methods: A cross-sectional association study was conducted at the Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Oman and the Centre of Medical Genetics, University of Antwerp, Antwerp, Belgium between August 2010 and September 2014. Microsatellites markers for nine non-syndromic genes were used to genotype the defective locus using the extracted DNA from family members. Sanger sequencing method was used to identify the disease causative mutation. Eazy linkage 5.05 was used to calculate the logarithm of odds score. Lasergene suite was used to detect the mutation position, and Phyre2, SMART, Rasmol, and GOR IV were used to predict the effects of the defect on protein structure and function. Results: The disease was linked to markers located on chromosome-2 and covering the OTOF (DFNB9) gene. A novel missense mutation that changed nucleotide C to G at position c.1469 and consequently the amino acid Proline to Arginine (P490R) on exon 15 was detected. Protein modeling analysis revealed the impact of the mutation on protein structure and the relevant C2C domain. The mutation seems to create a new protein isoform homologous to the complement component C1q. Conclusion: These findings suggest that the mutation found in C2C domain of the OTOF gene is likely to cause deafness in the studied family reflecting the importance of C2 domains of otoferlin in hearing loss.

Original languageEnglish
Pages (from-to)1068-1075
Number of pages8
JournalSaudi Medical Journal
Volume37
Issue number10
DOIs
Publication statusPublished - 2016

Fingerprint

Missense Mutation
Hearing Loss
Mutation
Deafness
Complement C1q
Oman
Genes
Proteins
Chromosomes, Human, Pair 2
Belgium
Medical Genetics
Proline
Biochemistry
Microsatellite Repeats
Arginine
Exons
Protein Isoforms
Nucleotides
Cross-Sectional Studies
Genotype

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy. / Al-Wardy, Nadia M.; Al-Kindi, Mohammed N.; Al-Khabouri, Mazin J.; Tamimi, Yahya; Van Camp, Guy.

In: Saudi Medical Journal, Vol. 37, No. 10, 2016, p. 1068-1075.

Research output: Contribution to journalArticle

@article{fcc5cb2023494da393f080d3c2097c5c,
title = "A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy",
abstract = "Objectives: To identify genetic defects in an Omani family diagnosed with deafness. Original Articles Methods: A cross-sectional association study was conducted at the Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Oman and the Centre of Medical Genetics, University of Antwerp, Antwerp, Belgium between August 2010 and September 2014. Microsatellites markers for nine non-syndromic genes were used to genotype the defective locus using the extracted DNA from family members. Sanger sequencing method was used to identify the disease causative mutation. Eazy linkage 5.05 was used to calculate the logarithm of odds score. Lasergene suite was used to detect the mutation position, and Phyre2, SMART, Rasmol, and GOR IV were used to predict the effects of the defect on protein structure and function. Results: The disease was linked to markers located on chromosome-2 and covering the OTOF (DFNB9) gene. A novel missense mutation that changed nucleotide C to G at position c.1469 and consequently the amino acid Proline to Arginine (P490R) on exon 15 was detected. Protein modeling analysis revealed the impact of the mutation on protein structure and the relevant C2C domain. The mutation seems to create a new protein isoform homologous to the complement component C1q. Conclusion: These findings suggest that the mutation found in C2C domain of the OTOF gene is likely to cause deafness in the studied family reflecting the importance of C2 domains of otoferlin in hearing loss.",
author = "Al-Wardy, {Nadia M.} and Al-Kindi, {Mohammed N.} and Al-Khabouri, {Mazin J.} and Yahya Tamimi and {Van Camp}, Guy",
year = "2016",
doi = "10.15537/smj.2016.10.14967",
language = "English",
volume = "37",
pages = "1068--1075",
journal = "Saudi Medical Journal",
issn = "0379-5284",
publisher = "Saudi Arabian Armed Forces Hospital",
number = "10",

}

TY - JOUR

T1 - A novel missense mutation in the C2C domain of otoferlin causes profound hearing impairment in an Omani family with auditory neuropathy

AU - Al-Wardy, Nadia M.

AU - Al-Kindi, Mohammed N.

AU - Al-Khabouri, Mazin J.

AU - Tamimi, Yahya

AU - Van Camp, Guy

PY - 2016

Y1 - 2016

N2 - Objectives: To identify genetic defects in an Omani family diagnosed with deafness. Original Articles Methods: A cross-sectional association study was conducted at the Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Oman and the Centre of Medical Genetics, University of Antwerp, Antwerp, Belgium between August 2010 and September 2014. Microsatellites markers for nine non-syndromic genes were used to genotype the defective locus using the extracted DNA from family members. Sanger sequencing method was used to identify the disease causative mutation. Eazy linkage 5.05 was used to calculate the logarithm of odds score. Lasergene suite was used to detect the mutation position, and Phyre2, SMART, Rasmol, and GOR IV were used to predict the effects of the defect on protein structure and function. Results: The disease was linked to markers located on chromosome-2 and covering the OTOF (DFNB9) gene. A novel missense mutation that changed nucleotide C to G at position c.1469 and consequently the amino acid Proline to Arginine (P490R) on exon 15 was detected. Protein modeling analysis revealed the impact of the mutation on protein structure and the relevant C2C domain. The mutation seems to create a new protein isoform homologous to the complement component C1q. Conclusion: These findings suggest that the mutation found in C2C domain of the OTOF gene is likely to cause deafness in the studied family reflecting the importance of C2 domains of otoferlin in hearing loss.

AB - Objectives: To identify genetic defects in an Omani family diagnosed with deafness. Original Articles Methods: A cross-sectional association study was conducted at the Department of Biochemistry, College of Medicine and Health Sciences, Sultan Qaboos University, Al-Khoud, Oman and the Centre of Medical Genetics, University of Antwerp, Antwerp, Belgium between August 2010 and September 2014. Microsatellites markers for nine non-syndromic genes were used to genotype the defective locus using the extracted DNA from family members. Sanger sequencing method was used to identify the disease causative mutation. Eazy linkage 5.05 was used to calculate the logarithm of odds score. Lasergene suite was used to detect the mutation position, and Phyre2, SMART, Rasmol, and GOR IV were used to predict the effects of the defect on protein structure and function. Results: The disease was linked to markers located on chromosome-2 and covering the OTOF (DFNB9) gene. A novel missense mutation that changed nucleotide C to G at position c.1469 and consequently the amino acid Proline to Arginine (P490R) on exon 15 was detected. Protein modeling analysis revealed the impact of the mutation on protein structure and the relevant C2C domain. The mutation seems to create a new protein isoform homologous to the complement component C1q. Conclusion: These findings suggest that the mutation found in C2C domain of the OTOF gene is likely to cause deafness in the studied family reflecting the importance of C2 domains of otoferlin in hearing loss.

UR - http://www.scopus.com/inward/record.url?scp=84989177856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989177856&partnerID=8YFLogxK

U2 - 10.15537/smj.2016.10.14967

DO - 10.15537/smj.2016.10.14967

M3 - Article

C2 - 27652356

AN - SCOPUS:84989177856

VL - 37

SP - 1068

EP - 1075

JO - Saudi Medical Journal

JF - Saudi Medical Journal

SN - 0379-5284

IS - 10

ER -